surmount 3 tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Tirzepatide after intensive lifestyle intervention

10.1136/thoraxjnl-2018-212463 Thorax

[25] [26] Based on its overexpression in a majority of human tumor cell lines and prevalence in chemotherapeutic-resistant tumors, GSTP1-1 is thought to play a role in the development of cancer and its potential resistance to drug treatment

doi: 10.1016/j.ejps.2025.107046 217 KianderWSinokkiANeuvonenMKidronHNiemiM

Small adjustments often make a noticeable difference

Semaglutide offers promising future implications beyond traditional obesity management

Astellas then pursued four additional lawsuits built on new but substantively similar patents, resulting in only two firms launching in 2024 while facing the threat of large damages claims [6]